Back to RLMD
BlackRock, Inc. RLMD Position History
Relmada Therapeutics, Inc. • Healthcare
Quarters held
19
Latest value
$153K
Q3 2026
Peak value
$26.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $140K |
| Q4 2025 | $6M |
| Q4 2025 | $7K |
| Q1 2026 | $232K |
| Q1 2026 | $23K |
| Q1 2026 | $8.7M |
| Q1 2026 | $38K |
| Q2 2026 | $282K |
| Q2 2026 | $1.9M |
| Q2 2026 | $1.5M |
| Q2 2026 | $26.6M |
| Q2 2026 | $21M |
| Q2 2026 | $63K |
| Q3 2026 | $609K |
| Q3 2026 | $1M |
| Q3 2026 | $806K |
| Q3 2026 | $14.5M |
| Q3 2026 | $11.5M |
| Q3 2026 | $153K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $153K | 40.6K | — | — |
| Q3 2026 | $11.5M | 3.05M | — | — |
| Q3 2026 | $14.5M | 3.83M | — | — |
| Q3 2026 | $806K | 213.8K | — | — |
| Q3 2026 | $1M | 276.2K | — | — |
| Q3 2026 | $609K | 161.6K | — | — |
| Q2 2026 | $63K | 9.2K | — | — |
| Q2 2026 | $21M | 3.04M | — | — |
| Q2 2026 | $26.6M | 3.85M | — | — |
| Q2 2026 | $1.5M | 213.8K | — | — |
| Q2 2026 | $1.9M | 279.9K | — | — |
| Q2 2026 | $282K | 40.7K | — | — |
| Q1 2026 | $38K | 5.5K | — | — |
| Q1 2026 | $8.7M | 1.25M | — | — |
| Q1 2026 | $23K | 3.3K | — | — |
| Q1 2026 | $232K | 33.4K | — | — |
| Q4 2025 | $7K | 1.5K | — | — |
| Q4 2025 | $6M | 1.24M | — | — |
| Q4 2025 | $140K | 29.0K | — | — |